Aligos Therapeutics Ownership | Who Owns Aligos Therapeutics?

Overview Forecast RevenueFinancials Chart

Aligos Therapeutics Ownership Summary

Aligos Therapeutics is owned by 2.04% institutional investors, 10.37% insiders, and 87.60% retail investors. Woodline partners lp is the largest institutional shareholder, holding 4.52% of ALGS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.40% of its assets in Aligos Therapeutics shares.

ALGS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aligos Therapeutics	2.04%	10.37%	87.60%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Woodline partners lp	468.20K	4.52%	$4.59M
Deep track capital, lp	444.11K	4.29%	$4.35M
Alyeska investment group	412.00K	3.98%	$4.04M
Sio capital management	335.94K	3.25%	$3.29M
Readystate asset management lp	203.11K	1.96%	$1.99M
Vanguard group	200.40K	1.93%	$1.87M
Adage capital partners gp	140.00K	1.35%	$1.37M
Renaissance	85.44K	0.82%	$796.34K
Baker bros. advisors lp	83.06K	0.80%	$813.94K
Hhlr advisors	76.25K	0.74%	$747.22K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sio capital management	335.94K	0.83%	$3.29M
Deep track capital, lp	444.11K	0.12%	$4.35M
Readystate asset management lp	203.11K	0.08%	$1.99M
Woodline partners lp	468.20K	0.02%	$4.59M
Hhlr advisors	76.25K	0.02%	$747.22K
Alyeska investment group	412.00K	0.01%	$4.04M
Quest partners	13.88K	0.01%	$129.32K
Baker bros. advisors lp	83.06K	0.01%	$813.94K
Drw securities	11.95K	0.00%	$111.37K
Golden state wealth management	2.67K	0.00%	$26.20K

Top Buyers

Holder	Shares	% Assets	Change
Verition fund management	71.25K	0.00%	71.25K
Readystate asset management lp	203.11K	0.08%	66.33K
Renaissance	85.44K	0.00%	30.43K
Vanguard group	200.40K	-	28.71K
Two sigma investments, lp	38.99K	0.00%	26.92K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-7.26M
Ecor1 capital	-	-	-6.39M
Versant venture management	-	-	-1.46M
Opaleye management	-	-	-1.26M
Pivotal bioventure partners investment advisor	-	-	-743.22K

New Positions

Holder	Shares	% Assets	Change	Value
Verition fund management	71.25K	0.00%	71.25K	$664.09K
Jane street group	24.29K	-	24.29K	$226.41K
Virtu financial	12.31K	0.00%	12.31K	$4.00K
Drw securities	11.95K	0.00%	11.95K	$111.37K
Hrt financial lp	11.37K	0.00%	11.37K	$106.00K

Sold Out

Holder	Change
Qube research	-2.00
Fmr	-10.00
Barclays	-15.00
Nelson, van denburg & campbell wealth management group	-80.00
Spire wealth management	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	6	-81.82%	211,095	-92.04%	2	0.31%	1	-93.75%	2	-66.67%
Sep 30, 2025	9	-75.68%	395,786	-85.37%	3	0.56%	6	-66.67%	-	-100.00%
Jun 30, 2025	37	5.71%	2,706,888	-15.60%	26	1.80%	19	-9.52%	8	-
Mar 31, 2025	35	2.94%	3,295,608	103.61%	39	5.89%	20	-9.09%	8	166.67%
Dec 31, 2024	1	-	80	-	-	-	1	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	97.53K	1.40%	-2.13K
Vanguard US Total Market Shares ETF	52.80K	0.86%	-
Vanguard Institutional Extnd Mkt Idx Tr	42.24K	0.61%	3.06K
Schwab US Small-Cap ETF™	25.39K	0.37%	35.00
Fidelity Extended Market Index	23.08K	0.33%	9.17K
Fidelity Series Total Market Index	8.20K	0.12%	4.43K
Fidelity Total Market Index	7.60K	0.11%	-16.00
Extended Equity Market Fund K	5.22K	0.09%	-104.00
Spartan Extended Market Index Pool F	5.48K	0.08%	157.00
NT Ext Equity Mkt Idx Fd - L	2.87K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 25, 2023	Nuechterlein Carole		Buy	$6.00M
Oct 25, 2023	Nuechterlein Carole		Buy	$3.00M
Oct 20, 2020	Novo Holdings A/S	-	Buy	$3.00M
Oct 20, 2020	Woiwode Thomas	-	Buy	$3.00M
Oct 20, 2020	Vivo Capital VIII, LLC	-	Buy	$7.25M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-

ALGS Ownership FAQ

Who Owns Aligos Therapeutics?

Aligos Therapeutics shareholders are primarily institutional investors at 2.04%, followed by 10.37% insiders and 87.59% retail investors. The average institutional ownership in Aligos Therapeutics's industry, Biotech Stocks , is 382.11%, which Aligos Therapeutics falls below.

Who owns the most shares of Aligos Therapeutics?

Aligos Therapeutics’s largest shareholders are Woodline partners lp (468.2K shares, 4.52%), Deep track capital, lp (444.11K shares, 4.29%), and Alyeska investment group (412K shares, 3.98%). Together, they hold 12.79% of Aligos Therapeutics’s total shares outstanding.

Does Blackrock own Aligos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aligos Therapeutics.

Who is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested?

Sio capital management is Aligos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.83% of its assets in 335.94K Aligos Therapeutics shares, valued at 3.29M$.

Who is the top mutual fund holder of Aligos Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aligos Therapeutics shares, with 1.40% of its total shares outstanding invested in 97.53K Aligos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools